Cargando…
Impact Of TP53 Gene Promoter Methylation On Chronic Lymphocytic Leukemia Pathogenesis And Progression
BACKGROUND: Chronic lymphocytic leukemia (CLL) is a malignant lymphoid disorder that results from the overgrowth of mature-looking lymphoid cells in the blood and lymphatic tissue. Various clinical presentations have been attributed to the disease as a result of the different underlying genetic and...
Autores principales: | Saeed, Waleed Haji, Eissa, Adil Abozaid, Al-Doski, Adnan Anwar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6883927/ https://www.ncbi.nlm.nih.gov/pubmed/31819692 http://dx.doi.org/10.2147/JBM.S221707 |
Ejemplares similares
-
COVID-19 Disease and Associated Thrombocytopenia: Pathogenesis and a Clue to the Etiology
por: Eissa, Adil Abozaid
Publicado: (2022) -
Telomere status in chronic lymphocytic leukemia with TP53 disruption
por: Guièze, Romain, et al.
Publicado: (2016) -
“Double-Hit” Chronic Lymphocytic Leukemia, Involving the TP53 and MYC Genes
por: Nguyen-Khac, Florence
Publicado: (2022) -
Development of chronic myelogenous leukemia in a case of chronic lymphocytic leukemia with Tp53 gene deletion
por: Gupta, A, et al.
Publicado: (2015) -
TP53 aberrations in chronic lymphocytic leukemia: an overview of the clinical implications of improved diagnostics
por: Campo, Elias, et al.
Publicado: (2018)